Agile Therapeutics
AGRX
#10447
Rank
NZ$17.73 M
Marketcap
NZ$2.57
Share price
0.00%
Change (1 day)
324.38%
Change (1 year)

Earnings for Agile Therapeutics (AGRX)

Earnings in 2024 (TTM): -NZ$24.37 Million

According to Agile Therapeutics 's latest financial reports the company's current earnings are NZ$21.56 Million. In 2023 the company made an earning of -NZ$22.19 Million a decrease over its 2022 earnings that were of -NZ$8.15 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Agile Therapeutics from 2013 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -NZ$24.37 Million9.79%
2023 -NZ$22.19 Million172.57%
2022 -NZ$8.15 Million-93.26%
2021 -NZ$0.13 Billion45.62%
2020 -NZ$82.9 Million161.98%
2019 -NZ$31.65 Million-2.78%
2018 -NZ$32.55 Million-27.47%
2017 -NZ$44.88 Million-10.16%
2016 -NZ$49.95 Million-14.2%
2015 -NZ$58.22 Million88.45%
2014 -NZ$30.9 Million41.72%
2013 -NZ$21.8 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$57.05 B-223,392.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$17.33 B-67,929.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$38.13 B-149,328.00%๐Ÿ‡บ๐Ÿ‡ธ USA
TherapeuticsMD
TXMD
NZ$0.01 M-100.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Antares Pharma
ATRS
NZ$0.11 B-538.45%๐Ÿ‡บ๐Ÿ‡ธ USA